U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 22-28, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 22-28, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 05/22/2022
Location: Virtual
Subject: American Psychiatric Association Annual Meeting: Artificial Intelligence and the Future of Psychiatry
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, and other registered guests

Event Date: 05/24/2022
Location: Silver Spring, MD
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Elizabeth Cushman, John Murphy, Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 05/24/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Anne Edwards, DeeDee Cada, Mark Del Monte, Tamar Magarik Haro (American Academy of Pediatrics);

Event Date: 05/24/2022
Location: Virtual
Subject: The Vaccination Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of Vaccinate Your Health and other public health partners working on increasing routine immunization rates

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 05/26/2022
Location: Virtual
Subject: Humane Society of the United States (HSUS) / Humane Society Legislative Fund (HSLF) Meeting
FDA Participant/Group: JAMES FLAHIVE; TRISTAN COLONIUS; MELISSA SAFFORD; DAVID STRAUSS; NAKISSA SADRIEH;
Non FDA Participant/Group: Representatives of Humane Society of the United States (HSUS) / Humane Society Legislative Fund (HSLF)

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/27/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Claire Babineaux-Fontenot (Feeding America);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/25/2022
Location: Virtual
Subject: Association for Accessible Medicines (AAM) Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Board members of the Association for Accessible Medicines

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/24/2022
Location: Virtual
Subject: Advanced Therapies 2022 Meeting; Panelist: Tackling Key Regulatory Challenges in the Advanced Therapies Space
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and regulatory stakeholders

Event Date: 05/24/2022
Location: Virtual
Subject: Duke-Margolis Center for Health Policy Translational Science in Drug Development; Surrogate Endpoints, Biomarkers, and More: Efficacy Outcomes in Rare Disease Gene Therapy Clinical Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia

Event Date: 05/24/2022
Location: Virtual
Subject: National Summit on the Sustained Management of COVID; Panelist: COVID Therapeutics: Pipeline, Preparation, Prioritization, and Future Distribution Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Association of State and Territorial Health Officials

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top